KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Invested Capital (2016 - 2025)

Abbott Laboratories' Invested Capital history spans 17 years, with the latest figure at $65.7 billion for Q4 2025.

  • For Q4 2025, Invested Capital rose 6.33% year-over-year to $65.7 billion; the TTM value through Dec 2025 reached $65.7 billion, up 6.33%, while the annual FY2025 figure was $65.7 billion, 6.33% up from the prior year.
  • Invested Capital for Q4 2025 was $65.7 billion at Abbott Laboratories, up from $64.2 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $65.7 billion in Q4 2025 and bottomed at -$10.5 billion in Q3 2021.
  • The 5-year median for Invested Capital is $10.0 billion (2025), against an average of $17.7 billion.
  • The largest annual shift saw Invested Capital tumbled 2034.01% in 2021 before it skyrocketed 4388.91% in 2025.
  • A 5-year view of Invested Capital shows it stood at $42.5 billion in 2021, then tumbled by 96.37% to $1.5 billion in 2022, then soared by 865.22% to $14.9 billion in 2023, then soared by 314.61% to $61.8 billion in 2024, then increased by 6.33% to $65.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Invested Capital are $65.7 billion (Q4 2025), $64.2 billion (Q3 2025), and $6.6 billion (Q2 2025).